Publicaciones en las que colabora con Rafael Cantón Moreno (22)

2024

  1. In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 69-77

2019

  1. Emergence and dissemination of colistin-resistant Klebsiella pneumoniae isolates expressing OXA-48 plus CTX-M-15 in patients not previously treated with colistin in a Spanish university hospital

    Diagnostic Microbiology and Infectious Disease, Vol. 93, Núm. 2, pp. 147-153

2018

  1. Susceptibility testing and detection of β-lactam resistance mechanisms in Enterobacteriaceae: a multicentre national proficiency study

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 612-619

2017

  1. Etestw versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: Results from PREMIUM, a European multicentre study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 2, pp. 431-436

2016

  1. Estudios de coste-efectividad con MALDI-TOF e impacto clínico

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, pp. 47-52

  2. High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307

2014

  1. Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: A multicenter external proficiency study using a well-defined collection of escherichia coli strains

    Journal of Clinical Microbiology, Vol. 52, Núm. 1, pp. 122-129

  2. Pandemic influenza A (H1N1) in non-vaccinated, pregnant women in Spain (2009-2010)

    Maternal and Child Health Journal, Vol. 18, Núm. 6, pp. 1454-1461

  3. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 1, pp. 164-167

  2. Antibiotics as selectors and accelerators of diversity in the mechanisms of resistance: From the resistome to genetic plasticity in the β-lactamases world

    Frontiers in Microbiology, Vol. 4, Núm. FEB

  3. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

  4. Social factors related to the clinical severity of influenza cases in Spain during the A (H1N1) 2009 virus pandemic

    BMC Public Health, Vol. 13, Núm. 1

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Effectiveness of pandemic and seasonal influenza vaccines in preventing pandemic influenza-associated hospitalization

    Vaccine, Vol. 30, Núm. 38, pp. 5644-5650

  3. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

  4. Score to identify the severity of adult patients with influenza A (H1N1) 2009 virus infection at hospital admission

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 10, pp. 2693-2701

  5. Sociodemographic factors and clinical conditions associated to hospitalization in influenza a (H1N1) 2009 virus infected patients in spain, 2009-2010

    PLoS ONE, Vol. 7, Núm. 3

2011

  1. Factores de riesgo de hospitalización por gripe (H1N1) 2009 y efectividad de intervenciones farmacológicas y no farmacológicas en su prevención. Estudio de casos y controles

    Revista Espanola de Salud Publica, Vol. 85, Núm. 1, pp. 3-15

2010

  1. Actividad comparativa de doripenem, meropenem e imipenem en aislados recientes obtenidos durante el estudio de vigilancia epidemiológica COMPACT-España

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 3, pp. 144-152